Global T-Cell Lymphoma Market Size, Share, and COVID-19 Impact Analysis, By Type of Lymphoma (Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angio-immuno-blastic T-cell Lymphoma, and Other Types of Lymphoma), By Type of Therapy (Radiotherapy, Chemotherapy, Immunotherapy, Stem Cell Transplantation, and Other Types of Therapies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

Industry: Healthcare
RELEASE DATE Oct 2022
REPORT ID SI1270
PAGES 222
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type of Lymphoma
      2. Market Attractiveness Analysis By Type of Therapy
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1.  Increase approvals
    3. Restraints
      1.  Side effects
    4. Opportunities
      1.   Increasing R&D
    5. Challenge

5.5.1.    High cost

  1. Global T-Cell Lymphoma Market Analysis and Projection, By Type of Lymphoma
    1. Segment Overview
    2. Peripheral T-cell Lymphoma
    3. Cutaneous T-cell Lymphoma
    4. Anaplastic Large Cell Lymphoma
    5. Angio-immuno-blastic T-cell Lymphoma
    6. Other Types of Lymphoma
  2. Global T-Cell Lymphoma Market Analysis and Projection, By Type of Therapy
    1.  Segment Overview
    2.   Radiotherapy
    3.  Chemotherapy
    4.  Immunotherapy
    5. Stem Cell Transplantation
    6. Other Types of Therapies
  3. Global T-Cell Lymphoma Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global T-Cell Lymphoma Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the T-Cell Lymphoma Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1.   Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
    2. SWOT Analysis
  6.  Merck KGaA
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  7.   Gilead Sciences Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  8.     TCR2 Therapeutics Inc
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  9.  Bluebird Bio Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  10.    Sorrento Therapeutics
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  11.   Fate Therapeutics
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  12.  Pfizer Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  13.  Amgen
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14.     Celgene Corporation
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  2.  Global Peripheral T-cell Lymphoma, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  3. Global Cutaneous T-cell Lymphoma, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  4. Global Anaplastic Large Cell Lymphoma, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  5. Global Angio-immuno-blastic T-cell Lymphoma, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  6. Global Other Types of Lymphoma, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  7. Global T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  8. Global Radiotherapy, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  9. Global Chemotherapy, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  10. Global Immunotherapy, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  11. Global Stem Cell Transplantation, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  12. Global Other Types of Therapies, T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  13. Global T-Cell Lymphoma Market, By Region, 2022-2030(USD Million)
  14. North America T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  15. North America T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  16. U.S.  T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  17. U.S.  T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  18. Canada T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  19. Canada T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  20. Mexico T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  21. Mexico T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  22. Europe T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  23. Europe T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  24. Germany T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  25. Germany T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  26. France T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  27. France T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  28. U.K.  T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  29. U.K.  T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  30. Italy T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  31. Italy T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  32. Spain T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  33. Spain T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  34. Asia Pacific T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  35. Asia Pacific T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  36. Japan T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  37. Japan T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  38. China T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  39. China T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  40. India T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  41. India T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  42. South America T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  43. South America T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  44. Brazil T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  45. Brazil T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  46. The Middle East and Africa T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD   Million)
  47. The Middle East and Africa T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)
  48. UAE T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  49. UAE T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)  
  50. South Africa T-Cell Lymphoma Market, By Type of Lymphoma, 2022-2030(USD Million)
  51. South Africa T-Cell Lymphoma Market, By Type of Therapy, 2022-2030(USD Million)

List of Figures 

  1. Global T-Cell Lymphoma Market Segmentation
  2.  T-Cell Lymphoma Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the T-Cell Lymphoma Market
  9. Top Winning Strategies, 2022-2030
  10. Top Winning Strategies, By Development, 2022-2030(%)
  11. Top Winning Strategies, By Company, 2022-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  T-Cell Lymphoma Market
  20.  T-Cell Lymphoma Market Segmentation, By Type of Lymphoma
  21.  T-Cell Lymphoma Market For Peripheral T-cell Lymphoma, By Region, 2022-2030 ($ Million)
  22.  T-Cell Lymphoma Market For Cutaneous T-cell Lymphoma, By Region, 2022-2030 ($ Million)
  23.  T-Cell Lymphoma Market For Anaplastic Large Cell Lymphoma, By Region, 2022-2030 ($ Million)
  24.  T-Cell Lymphoma Market For Angio-immuno-blastic T-cell Lymphoma, By Region, 2022-2030 ($ Million)
  25.  T-Cell Lymphoma Market For Other Types of Lymphoma, By Region, 2022-2030 ($ Million)
  26. T-Cell Lymphoma Market Segmentation, By Type of Therapy
  27.  T-Cell Lymphoma Market For Radiotherapy, By Region, 2022-2030 ($ Million)
  28.  T-Cell Lymphoma Market For Chemotherapy, By Region, 2022-2030 ($ Million)
  29.  T-Cell Lymphoma Market For Immunotherapy, By Region, 2022-2030 ($ Million)
  30.  T-Cell Lymphoma Market For Stem Cell Transplantation, By Region, 2022-2030 ($ Million)
  31.   T-Cell Lymphoma Market For Other Types of Therapies, By Region, 2022-2030 ($ Million)
  32. Procter & Gamble: Net Sales, 2022-2030 ($ Million)
  33. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  34. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  35. PHYTOMER: Net Sales, 2022-2030 ($ Million)
  36. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  37. PHYTOMER: Revenue Share, By Region, 2022 (%)
  38. Deka Corporation: Net Sales, 2022-2030 ($ Million)
  39. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  40. Deka Corporation: Revenue Share, By Region, 2022 (%)
  41. Johnson & Johnson: Net Sales, 2022-2030 ($ Million)
  42. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  43. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  44. Unilever Plc.: Net Sales, 2022-2030 ($ Million)
  45. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  46. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  47. Kao Corporation: Net Sales, 2022-2030 ($ Million)
  48. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  49. Kao Corporation: Revenue Share, By Region, 2022 (%)
  50. ZO Skin Health, Inc.: Net Sales, 2022-2030 ($ Million)
  51. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  52. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  53. L’Oreal Paris: Net Sales, 2022-2030 ($ Million)
  54. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  55. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  56. Shiseido Company Limited: Net Sales, 2022-2030 ($ Million)
  57. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  58. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  59. Estee Lauder Companies, Inc.: Net Sales, 2022-2030 ($ Million)
  60. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  61. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:112
Pages:222
Countries covered:17
Companies covered::10
Forecast CAGR:8.50 %
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies